Sir,

In 1987, the non-steroidal anti-inflammatory drug (NSAID) suprofen was withdrawn from the market due to ∼400 cases of the so-called 'acute flank pain syndrome' (AFPS) which was ascribed to the drug \[[@ref1]\]. AFPS, characterized by severe flank pain, acute renal failure and recovery within 1 or 2 weeks, was most common in young males \[[@ref2]\]. After withdrawal of suprofen, only a few reports have been published, associating AFPS with ingestion of other types of NSAIDS, binge drinking or both \[[@ref3]\]. In Iceland, the nephrologists have been aware of AFPS since the mid-1990s. By now, typical patients are managed with analgesics and by observation after minimal investigation.

We screened the records of patients aged 18--41 years who received the diagnosis acute renal failure at Landspitali University Hospital during the period 1998--2007, and patients with AFPS were identified. AFPS was defined as severe flank or abdominal pain upon admission in combination with acute renal failure (serum creatinine concentration \>50% increase of baseline or upper reference range), both features unexplained except for the possible intake of an NSAID, ethanol or both. Information about total and over-the-counter sales of ibuprofen and diclofenac during the study period was collected.

There were 106 cases of acute renal failure. Of these, 21 (20%) had AFPS which amounts to an average incidence of 20.1/million/year. The incidence increased during the study period ([Table 1](#tab1){ref-type="table"}). None of the AFPS patients had a history of kidney disease. Eighteen patients were males, and the median age was 26 (18--35) years. There was information about recent consumption of NSAIDs in 15 patients (ibuprofen in 8, diclofenac in 2, both in 2 and unknown type in 3), ethanol in 15 patients, either in 20 patients and both in 9 patients. The laboratory results are shown in [Table 1](#tab1){ref-type="table"}. The sales figures of the NSAIDs were high, and they increased during the study period, especially the over-the-counter sales of ibuprofen ([Table 2](#tab2){ref-type="table"}).

###### 

The year of diagnosis and the laboratory results of the patients who sought assistance in the emergency room at Landspitali University Hospital because of acute flank pain syndrome

  Year   Serum creatinine^a^ (µmol/L)   CRP (mg/L)   Urine density (g/mL)   Urine protein   Urine red cells (per hpf)   Urine white cells (per hpf)   US kidneys   Kidney biopsy   
  ------ ------------------------------ ------------ ---------------------- --------------- --------------------------- ----------------------------- ------------ --------------- --------
  1998   179                            122 (7)                             1.007           \+                          10--25                        1--2         ↑echo           normal
  1998   238                            181 (6)                             1.007           \+                          2--5                          2--5         ↑echo           ATN
  2000   178                            137 (5)                             1.006           \+                          5--8                          3--5         ↑echo           
  2001   236                            127 (10)     25                     1.006           \+                          5--10                         0--2                         
  2003   330                            99 (13)                             1.010           +++                         5--10                         1--2         ↑echo           ATN
  2003   215                            97 (7)       25                     1.010           +++                         1--2                          1--2         normal          
  2004   256                            112 (7)      38                     \<1.005         +++                         0--1                          2--5         ↑echo           
  2004   189                                         56                     1.005           +++                         0--2                          2--5         normal          
  2005   251                            108 (11)     14                     \<1.005         ++                          1--2                          0--5         ↑echo           
  2005   243                            100 (4)                             \<1.005         ++                          0                             0--1                         
  2005   256                            204 (4)      22                     1.010           +++                         2--5                          2--5         normal          
  2005   166                            93 (24)      25                     \<1.005         (+)                         5--10                         2--5                         
  2006   137                            85 (10)      6                      1.020           −                           0                             5--10        normal          
  2006   202                            104 (20)     80                     1.010           −                           0--1                          2--5         ↑echo           
  2006   427                            158 (5)      \<3                    1.025           +++                         5--10                         1--2         ↑echo           
  2007   252                            104 (6)                             \<1.005         −                           2--5                          1--2                         
  2007   381                            207 (6)      24                     \<1.005         +++                         1--2                          1--2                         
  2007   261                            76 (15)      21                     1.015           +++                         5--10                         10--25                       
  2007   529                            97 (23)      30                     1.020           +++                         2--5                          2--5                         
  2007   320                            85 (13)      25                     1.015           ++                          0--1                          0--1         ↑echo           
  2007   286                            97 (79)      51                     1.010           −                           1--2                          0--1                         

Gaps indicate missing information.

CRP, C-reactive protein; hpf, high-power field; US, ultrasonography; ↑echo, increased echogenicity; ATN, acute tubular necrosis.

^a^Reference range 100 µmol/L for males and 90 µmol/L for females.

###### 

The sales of ibuprofen and diclofenac in the Nordic countries according to the Icelandic Medicines Agency (Iceland), the Danish Medicines Agency (Denmark), Folkhelseinstituttet (Norway) and Apotekens Service AB (Sweden)

  Country   Year   Ibuprofen total   Ibuprofen OTC   Diclofenac total   Diclofenac OTC
  --------- ------ ----------------- --------------- ------------------ ----------------
  Iceland   1998   12.8              4.2             14.5               
  Iceland   1999   14.8              5.7             18.0               
  Iceland   2000   16.8              7.2             17.5               
  Iceland   2001   20.0              8.7             16.8               
  Iceland   2002   25.3              14.1            17.2               0.2
  Iceland   2003   30.7              19.5            16.9               0.2
  Iceland   2004   33.8              21.6            17.3               0.2
  Iceland   2005   35.1              22.0            20.1               0.7
  Iceland   2006   36.0              22.6            20.3               0.6
  Iceland   2007   29.8              19.0            20.7               1.2
  Denmark   2007   21.0              6.2             8.2                
  Norway    2007   16.8              9.8             9.6                
  Sweden    2007   7.1               5.3             4.2                0.5

The sales are given in defined daily doses/1000 inhabitants/day.

OTC, over-the-counter.

This retrospective study underestimated the countrywide incidence of AFPS; an unknown number of patients who sought the advice of their general practitioners were never admitted to the hospital since the consultant nephrologist recognized AFPS upon description. In spite of this, the study revealed the largest body of material of AFPS that has been reported since the suprofen experience. Moreover, the study showed that AFPS is a common presentation of acute renal failure in young adults in Iceland.

The scarcity of reports indicates that AFPS is uncommon. However, AFPS may be underreported. The incidence of AFPS is high in Iceland which can possibly be explained by heavy consumption of NSAIDs in a country where binge drinking is common. There may be a causal relationship between the simultaneous increases in the incidence of AFPS and the over-the-counter sales of ibuprofen.

There is uncertainty of whether the kidneys recover completely or whether there is residual renal damage after AFPS.
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